Book Stuff

Life Is Short, Laundry Is Eternal 
#8 In Fatherhood (paperback)
#7 In Fatherhood (Kindle)
#1 In Diabetes (paperback)
#6 In Diabetes (Kindle)

Add my book to your GoodReads Shelf

Life Is Short, Laundry Is Eternal: Confessions of a Stay-at-Home Dad

Social Media

 

 

Life Is Short, Laundry Is Eternal is a Mom’s Choice Awards® Gold Recipient

Winner 2011 Advocating for Another

 

Winner 2011 Editor's Choice


Recent Blog Entries
504 A1C ADA ADG Adrenaline Advocacy Anniversary Apidra Arden Arden's Writing Ask Me Anything Awards Basal Baseball Basketball bBlogger Bbook BGnow Big Blue Test Blogger Blue Friday book Books Canada Carbs Caregiver cConfessions of a Stay-at-Home Dad CGM charity CHOP Coco Cole community Confessions of a Stay-at-Home Dad ConsultYourDoctor Contest Coxsackie DayOfDiabetes DayOne Dblog D-Blog Day D-Blog Week DexCom D-free post diabetes Diabetes Art Day Diabetes Awareness Month Diabetes Blog Week Diabetes Hands Diabetes Mine DiabetesDaily Disney DOC D-Politics D-Resource DSMA D-Supplies endo Explicit FaceBook family Father's Day Faustman Favorite Post FDA Flexifix Follow Up Free Stuff Freelance FreeStyle fundraising G uest Post gGlucose Meter GiveAway Glucagon Glucose Meter Guest Post Guilty Health Howard Stern HuffPostLive Hurricane Irene iBGStar IDF In the News Instagram Insulet Insulin Insulin Pump Insurance Interview iPhone Irene JDRF John Sarno Katie Couric Kelly ketoacidosis Ketone LaceUp4Diabetes Life is Short Lilly Love MDI med Media Medtronic MLB MLK Mom's Choice Award MultiClix NLDS Novo Nordisk NPR OBX OffTopic Oklahoma Tornado OmniPod Parenting Perspective Petition Pharma Phillies PodCast pPerspective Pre-Bolus Prescription Preventative PWD reader mail Recall research review Roche Sanofi School Sick Day Site News SleepOver Smaller OmniPod Social Media Soft Ball Softball Spanish Speaking Spring Infusion Set SpryPub sStrip Safely Stay-at-home Dad Steve Jobs Stress Strip Safely technology Teen TheDX TipsNTricks Transparency Travel TrialNet ttechnology TuDiabetes Twitter ty type I video Walk WEGO World Diabetes Day
Search

« A Real Kindness | Main | Ardens Numbers »
Tuesday
Nov182008

Possible Cure Announced

JDRF Funded Research Shows Promise for Prevention, Reversal of Type 1 Diabetes

New York, NY, November 18, 2008 -- Researchers at the University of California, San Francisco have reported that two common cancer drugs have been used to block and reverse type 1 diabetes in mice. The JDRF-funded study, published in The Proceedings of the National Academy of Sciences, was led by Jeffrey Bluestone, Ph.D., director of the Diabetes Center at UCSF and an expert in the field of autoimmunity.

"The findings suggest that kinase inhibitors -- successfully used in cancer -- may provide an important new therapeutic approach for treatment of new onset type 1 diabetes and potentially other autoimmune disorders," said JDRF Director of Immunology Teodora Staeva, Ph.D.

The drugs -- Imatinib and Sunitnib, sold as Gleevec and Sutent, respectively -- are used to treat cancer by blocking tyrosine kinases, an enzyme that modify cells' signaling proteins through a simple biochemical change.  Kinases trigger cell growth, and it is widely believed that tyrosine kinases are a contributing factor to autoimmune diseases and cancer.  The researchers hypothesized that tyrosine kinases may also serve as a trigger to the body's attack on the immune system.

The researchers at the University of California, San Francisco treated non-diabetic mice prone to developing diabetes with imatinib or sunitinib, and found that the drugs prevented the onset of diabetes past the seven-week treatment.  Mice that already developed diabetes were treated with the drugs and results concluded that after two months of treatment, 80 percent no longer had diabetes.

The science was conducted as part of the Immune Tolerance Network, partially funded by JDRF.

PrintView Printer Friendly Version

EmailEmail Article to Friend

Reader Comments

There are no comments for this journal entry. To create a new comment, use the form below.

PostPost a New Comment

Enter your information below to add a new comment.

My response is on my own website »
Author Email (optional):
Author URL (optional):
Post:
 
Some HTML allowed: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>